MDxHealth
GenomeWeb Top 40 Rises 2 Percent in September, Largely Tracking Broader Market
Of the 40 firms tracked by GenomeWeb, 21 saw their stock prices rise month over month and 19 saw their shares decrease in value.
MDxHealth Prices $40M Ordinary Share Public Offering
MDxHealth also said a strategic partner is purchasing 1,500,000 ordinary shares in the offering directly from the company rather than through the underwriters.
MDxHealth Q2 Revenues Rise 33 Percent
The company said tissue-based testing volume was up 15 percent, while liquid-based testing volume grew 35 percent.
MDxHealth Reports 35 Percent Q1 Revenue Growth, Signs $100M Loan Agreement With OrbiMed
The company also raised its 2024 revenue guidance to a new range of $83 million to $85 million.
GenomeWeb Top 40 up 2 Percent in March, Following Broader Market
The Dow Jones Industrial Average and Nasdaq also gained 2 percent, while the Nasdaq Biotech Index was essentially flat.